Diploma PLC (LON:DPLM - Get Free Report)'s share price shot up 15.1% on Wednesday . The stock traded as high as GBX 5,025 ($67.45) and last traded at GBX 4,860 ($65.23). 975,747 shares were traded during mid-day trading, an increase of 115% from the average session volume of 453,933 shares. The stock had previously closed at GBX 4,222 ($56.67).
Diploma Price Performance
The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80. The company's 50-day moving average price is GBX 3,967.56 and its 200-day moving average price is GBX 4,257.56. The company has a market cap of £6.35 billion, a P/E ratio of 54.76, a P/E/G ratio of 2.82 and a beta of 0.75.
Diploma (LON:DPLM - Get Free Report) last released its quarterly earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.08) earnings per share (EPS) for the quarter. Diploma had a return on equity of 13.18% and a net margin of 9.25%. As a group, sell-side analysts predict that Diploma PLC will post 163.7995512 earnings per share for the current fiscal year.
Insider Buying and Selling at Diploma
In related news, insider David S. Lowden acquired 750 shares of the company's stock in a transaction dated Friday, March 21st. The shares were bought at an average price of GBX 3,928 ($52.72) per share, for a total transaction of £29,460 ($39,543.62). Also, insider Katie Bickerstaffe bought 44 shares of the firm's stock in a transaction that occurred on Wednesday, May 21st. The stock was purchased at an average cost of GBX 4,867 ($65.33) per share, with a total value of £2,141.48 ($2,874.47). In the last quarter, insiders have bought 1,346 shares of company stock worth $5,393,173. Corporate insiders own 0.52% of the company's stock.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
